RedHill Biopharma Ltd.
RedHill Biopharma Ltd.（RDHL）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
rdhl · 股价预测 · 10 位分析师（近3月）· FMP · 更新于 2026年6月9日
分析师评级与共识
基于过去 3 个月内 10 位华尔街分析师
Buy
10 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $1.02
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $1.03 | ↑ 1.02% |
1-day model range: $1.03–$1.04. Peak: $1.04 (+1.02%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $1 | -50.0% |
| 2028 | $0 | -62.5% |
| 2029 | $0 | -67.2% |
| 2030 | $0 | -69.2% |
| 2031 | — | -70.2% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · RDHL · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2021-09-15 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2021-08-31 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2021-05-28 | WBB Securities | Downgrade ↓ | Strong Buy→Buy |
| 2021-05-18 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2020-09-11 | BTIG | Maintains | Buy→Buy |
| 2020-03-05 | H.C. Wainwright | Maintains | Buy→Buy |
| 2019-07-12 | WBB Securities | Upgrade ↑ | Buy→Strong Buy |
| 2019-03-12 | WBB Securities | Maintains | Speculative Buy→Buy |
| 2018-06-25 | Ladenburg Thalmann | Maintains | Buy→Buy |
| 2018-01-26 | Nomura | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on RedHill Biopharma Ltd. (RDHL) stock. Of the recent 14 rating actions, 1 were upgrades and 1 were downgrades. 10 analysts currently cover RDHL.
分析师推荐趋势
RDHL analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$68M
↑ 226.9% YoY
Revenue Next Year
$9M
↓ 86.8% YoY
EPS This Year
$-70.00
EPS Next Year
$-80.00
↑ 14.3% YoY
EPS ForecastReported vs Estimated
Analysts forecast RDHL EPS of $-70.00 for the current fiscal year, based on estimates from 13 analysts. The RDHL revenue forecast is $68M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
RDHL 股价预测由两类独立数据源支撑：来自 10 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。RDHL 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
RDHL 的短期预测（明日）为 $1.03（+1.02%）。 RDHL 对 2027 年的股价预测均值为 $1。 RDHL 对 2030 年的预测区间为 $0–$0。
RedHill Biopharma Ltd. 在 NASDAQ 上市，代码 RDHL。RDHL 在 2027 年的整体展望偏积极，在覆盖分析师中约 100% 对应 Buy 共识。
常见问题
RDHL 预测 · 8 个问题根据 10 位华尔街分析师，RDHL 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $1.02，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.